Quantcast

Latest National Institute of Health Stories

early celiac sign
2014-07-04 03:30:55

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH-funded study finds higher celiac risk in Sweden than US, elsewhere More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5. The findings are from The Environmental Determinants of Diabetes in Youth consortium, or TEDDY. The National Institutes of Health-funded study, published July...

2014-07-03 11:16:59

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH study suggests people with either should be monitored for both Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis by scientists at the National Institutes of Health and George...

2014-07-02 12:51:45

NIH/National Institute of Diabetes and Digestive and Kidney Diseases Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association. The...

2014-07-01 08:30:44

SAN DIEGO, July 1, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received two NIH small business grants which will fund the development of bispecific antibodies for two of its anti-bacterial immunotherapies. Sorrento's highly diverse, fully human G-MAB(®) library and proprietary antibody conjugation technology platforms have...

2014-06-27 23:05:37

An eight-essay collection of articles published in the Journal of the International Neuropsychological Society confirms the validity of the Cognition Battery element of the National Institutes of Health (NIH) Toolbox for the Assessment of Neurological and Behavioral Function New York, NY (PRWEB) June 27, 2014 The Journal of the International Neuropsychological Society(JINS) is published by Cambridge University Press on behalf of the International Neuropsychological Society. This month the...

2014-06-23 08:28:08

BOSTON, June 23, 2014 /PRNewswire/ -- Rhythm announced today the presentation of results from a clinical trial that evaluated the effect of RM-493, the company's novel melanocortin 4 receptor (MC4R) agonist, on resting energy expenditure in obese subjects. Analysis of the data indicates that RM-493 increased resting energy expenditure significantly in this trial. The study results were presented by Monica Skarulis, MD, an investigator at the National Institutes of Health (NIH), at the...

2014-06-20 08:23:13

~Company Recognized as Notable Recipient of SBIR Grants CHARLOTTESVILLE, Va., June 20, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced that CBO Vince Aurentz will be presenting at the BIO 2014 meeting during the BIO Business Forum on Tuesday, June 24 at 11:00 a.m. in the Solana Beach Room. Aurentz's presentation, "Recreating Human Disease Biology for Discovery and Development of Safer and More Effective New Drugs", will focus on HemoShear's...

2014-06-18 23:06:59

$3 Million NIH Grant to Fund Effort to Rescue Tissue That Would be Destroyed Charlottesville, Va. (PRWEB) June 18, 2014 The University of Virginia Health System has been awarded more than $3 million from the National Institutes of Health’s National Cancer Institute to support and expand a critically important program that makes tissue samples available for research on diseases ranging from breast cancer to lung disease. The five-year grant enables UVA to launch a partnership with...

2014-06-10 20:20:23

WASHINGTON, June 10, 2014 /PRNewswire-USNewswire/ -- NASA astronaut Michael Hopkins met Stephen I. Katz, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases on Tuesday at National Institutes of Health (NIH) campus in Bethesda, Maryland, where they discussed the importance of research taking place aboard the International Space Station, including NIH-funded investigations. http://photos.prnewswire.com/prnvar/20081007/38461LOGO Hopkins also made a...

2014-06-06 12:24:27

SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to T Cell Receptor (TCR)-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related